A testing algorithm for determination of HER2 status in patients with breast cancer.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 11848614)

Published in Ann Clin Lab Sci on January 01, 2002

Authors

Dawn W Nichols1, Daynna J Wolff, Sally Self, John S Metcalf, Donna Jacobs, Rayna Kneuper-Hall, John C Cate

Author Affiliations

1: Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston 29425, USA.

Articles by these authors

American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genet Med (2011) 1.26

Developing a sustainable process to provide quality control materials for genetic testing. Genet Med (2005) 1.23

An innovative microarray strategy identities informative molecular markers for the detection of micrometastatic breast cancer. Clin Cancer Res (2005) 1.21

Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res (2003) 1.17

Langerhans cell sarcoma. Am J Dermatopathol (2006) 1.15

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg (2004) 1.14

Evaluation of urovysion and cytology for bladder cancer detection: a study of 1835 paired urine samples with clinical and histologic correlation. Cancer Cytopathol (2013) 1.08

American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders. Genet Med (2013) 1.07

The relationship between continuity of care and trust with stage of cancer at diagnosis. Fam Med (2004) 0.97

Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years. Arch Pathol Lab Med (2006) 0.95

Clinical, genetic, and biophysical characterization of a homozygous HERG mutation causing severe neonatal long QT syndrome. Pediatr Res (2003) 0.93

Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratories. Genet Med (2005) 0.93

Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int (2005) 0.93

Utility of Interphase FISH Panels for Routine Clinical Cytogenetic Evaluation of Chronic Lymphocytic Leukemia and Multiple Myeloma. J Assoc Genet Technol (2004) 0.89

Merkel cell carcinoma in situ. J Cutan Pathol (2005) 0.89

HER2 testing: a review of detection methodologies and their clinical performance. Expert Rev Mol Diagn (2007) 0.89

Detection of an apparent homozygous 3120G>A cystic fibrosis mutation on a routine carrier screen. J Mol Diagn (2006) 0.88

Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a university children's hospital. Ann Clin Lab Sci (2002) 0.87

HER-2 fluorescence in situ hybridization: results from the survey program of the College of American Pathologists. Arch Pathol Lab Med (2006) 0.87

Histologic patterns of polyethylene glycol-liposomal doxorubicin-related cutaneous eruptions. Am J Dermatopathol (2006) 0.87

Multicentric reticulohistiocytosis responding to tumor necrosis factor-alpha inhibition in a renal transplant patient. J Rheumatol (2005) 0.87

Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing. Expert Rev Mol Diagn (2014) 0.87

Altered promoter usage characterizes monoallelic transcription arising with ERBB2 amplification in human breast cancers. Genes Chromosomes Cancer (2006) 0.85

Multicenter characterization and validation of the intron-8 poly(T) tract (IVS8-T) status in 25 Coriell cell repository cystic fibrosis reference cell lines for cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation assays. Clin Chem (2004) 0.84

Cutaneous involvement by Burkitt lymphoma. J Am Acad Dermatol (2006) 0.84

Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant (2003) 0.83

Adenovirus in kidney transplantation: an emerging pathogen? Transplantation (2004) 0.83

Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association. Circulation (2015) 0.82

Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study. Surgery (2005) 0.82

Fine-needle aspiration of a primary mediastinal large B-cell lymphoma: a case report with cytologic, histologic, and flow cytometric considerations. Diagn Cytopathol (2005) 0.81

Mitochondrial disorders of DNA polymerase γ dysfunction: from anatomic to molecular pathology diagnosis. Arch Pathol Lab Med (2011) 0.80

The utility of fluorescence in situ hybridization (FISH) analysis in diagnosing graft versus host disease following orthotopic liver transplant. Ann Clin Lab Sci (2011) 0.80

Validation of fluorescence in situ hybridization using an analyte-specific reagent for detection of abnormalities involving the mixed lineage leukemia gene. Arch Pathol Lab Med (2012) 0.80

Association of age with fluorescence in situ hybridization abnormalities in multiple myeloma reveals higher rate of IGH translocations among older patients. Leuk Lymphoma (2012) 0.79

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study. Ann Surg Oncol (2010) 0.79

Anemia, cough, and acute renal failure in a teenager: case presentation and review. Fetal Pediatr Pathol (2007) 0.79

Section E6 of the ACMG technical standards and guidelines: chromosome studies for acquired abnormalities. Genet Med (2005) 0.78

Clonal diversity analysis using SNP microarray: a new prognostic tool for chronic lymphocytic leukemia. Cancer Genet (2011) 0.78

Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol (2010) 0.78

Prevalence of aneuploidies in South Carolina in the 1990s. Genet Med (2002) 0.77

Tetraploidy and 5q deletion in myelodysplastic syndrome: a case report. Cancer Genet Cytogenet (2008) 0.77

Mosaic duplication 1(q11q44) in an infant with nephroblastomatosis and mineralization of extraplacental membranes. Pediatr Dev Pathol (2004) 0.77

College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genet Med (2011) 0.77

Comparison Between HER2, Estrogen Receptors and Progesterone Receptors in Primary Breast Carcinomas and Matched Lymph Node Metastases. Turk Patoloji Derg (2016) 0.77

Pediatric T-cell acute lymphoblastic leukemia with aberrations of both MLL loci. Cancer Genet Cytogenet (2006) 0.76

Establishment of epidermal cell lines derived from the skin of the Atlantic bottlenose dolphin (Tursiops truncatus). Anat Rec A Discov Mol Cell Evol Biol (2005) 0.76

"Low-Fat" Pseudoangiomatous Spindle Cell Lipoma: A Rare Variant With Loss of 13q14 Region. Am J Dermatopathol (2015) 0.75

Can scleromyxedema be differentiated from nephrogenic fibrosing dermatopathy by the distribution of the infiltrate? J Cutan Pathol (2006) 0.75

The Prothrombin 20209C>T Sequence Variant: To Test or Not to Test. J Assoc Genet Technol (2007) 0.75

Membranoproliferative glomerulonephritis associated with influenza A infection. Am J Med Sci (2012) 0.75

Jumping translocation of 1q in BCR/ABL-positive acute lymphoblastic leukemia. Cancer Genet Cytogenet (2007) 0.75

Cutaneous presentation of T-cell prolymphocytic leukemia. Cutis (2013) 0.75

Cytogenetics caseload survey summary 2012. J Assoc Genet Technol (2012) 0.75

A case of infantile acute myelogenous leukemia with MLL-MLL10 fusion caused by insertion of 11q into 10p. Cancer Genet Cytogenet (2005) 0.75